Moreover, spatial comparison of hypoxia and vascular markers and GLUT-1 can inform if GLUT-1 expression is related to glycolytic phenotype of cancer cells and to obesity/diabetes status of the patients. This evidence concerns the gene SLC2A1 and diabetes mellitus.